Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Moscow Micex - RTS  >  Sberbank of Russia    SBER   RU0009029540

SBERBANK OF RUSSIA

(SBER)
  Report
End-of-day quote. End-of-day quote Moscow Micex - RTS - 11/24
245.72 RUB   +2.88%
02:36aSBERBANK OF RUSSIA : joint project with Mail.ru is in limbo
AQ
11/23SBERBANK OF RUSSIA :  informs about PDMR transaction
EQ
11/23BEST CUSTOMER EXPERIENCE WITH AI : Sber wins six awards at iCXA
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Sberbank of Russia : to help implement Russia's pharmaceutical industry development strategy

10/19/2020 | 09:05am EST

Sberbank has signed a cooperation agreement with JSC Pharmasyntez, a pharmaceutical leader in Russia. The agreement was inked by Anatoly Popov, Deputy Chairman of the Executive Board at Sberbank, and Vikram Punia, President of Pharmasyntez.

The parties have agreed to join their effort in developing the pharmaceutical industry in Russia in line with the Pharma 2030 development strategy. The agreement covers interaction in multiple areas, including co-investment, debt and equity finance, long-term financing of Pharmasyntez projects, digitization and streamlining of its production, and the adoption of new technology.

Anatoly Popov, Deputy Chairman of the Executive Board, Sberbank:

'We've been working with Pharmasyntez for years across a wide range of issues. It's our long-standing customer and a reliable partner with high innovative potential. Earlier, we had approved a RUB15 bln lending limit for the company. The agreement we've signed today and our growing partnership will ensure an increase in the exportation of medications and the introduction of innovations into production while also helping to accelerate the development of this strategically important industry, which has people's lives depending on its continuous operation.'

Vikram Punia, President of Pharmasyntez Group of Companies:

'Sberbank has been our strategic financial partner for years. Combining the efforts of Pharmasyntez and Sberbank will contribute to the modernization of production with the introduction of advanced technology and the formation of a stable innovation foundation for Pharmasyntez. The attracted investment and the introduction of new technology will be used to conduct clinical trials of candidate drugs in Russia and abroad and to develop investment activities, as well as to ensure high growth rates for Pharmasyntez Group until 2025.'

Disclaimer

Sberbank of Russia published this content on 19 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 October 2020 13:04:09 UTC


© Publicnow 2020
All news about SBERBANK OF RUSSIA
02:36aSBERBANK OF RUSSIA : joint project with Mail.ru is in limbo
AQ
11/23SBERBANK OF RUSSIA :  informs about PDMR transaction
EQ
11/23BEST CUSTOMER EXPERIENCE WITH AI : Sber wins six awards at iCXA
PU
11/23SBERBANK OF RUSSIA : rolls our mortgage refinancing for new homes
PU
11/20Russia's largest lender Sberbank expects AI profit expansion
RE
11/19SBERBANK OF RUSSIA : New customers of Sber can invest in stocks free of charge f..
PU
11/19SBERBANK OF RUSSIA : and RUSAL to implement ESG strategy
PU
11/19COVID-19 CRISIS : a shot in the arm for Russian e-commerce
RE
11/18SISTEMA PUBLICFINANCIAL : attracts first ESG financing from Sberbank
AQ
11/18SBERBANK OF RUSSIA : Sber, Moscow Government, and Government of Moscow Region to..
PU
More news
Financials
Sales 2020 2 218 B 29 231 M 29 231 M
Net income 2020 698 B 9 194 M 9 194 M
Net Debt 2020 - - -
P/E ratio 2020 7,54x
Yield 2020 6,59%
Capitalization 5 132 B 67 214 M 67 650 M
Capi. / Sales 2020 2,31x
Capi. / Sales 2021 2,23x
Nbr of Employees 276 598
Free-Float 45,1%
Chart SBERBANK OF RUSSIA
Duration : Period :
Sberbank of Russia Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SBERBANK OF RUSSIA
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Average target price 294,21 RUB
Last Close Price 238,84 RUB
Spread / Highest target 95,3%
Spread / Average Target 23,2%
Spread / Lowest Target -6,63%
EPS Revisions
Managers
NameTitle
Herman Gref Chief Executive Officer & Member-Supervisory Board
Anton Germanovich Siluanov Chairman-Supervisory Board
Alexandra Buriko Chief Financial Officer & Head-Finance
David Rafalovsky Chief Technology Officer & Executive VP
Sergei Mikhaylovich Ignatiev Deputy Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SBERBANK OF RUSSIA-6.25%67 214
JPMORGAN CHASE & CO.-17.81%349 233
BANK OF AMERICA CORPORATION-23.88%231 928
INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED-23.50%206 610
CHINA MERCHANTS BANK CO.. LTD.20.81%141 585
ROYAL BANK OF CANADA1.54%113 617